These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 355011)

  • 1. Comparison studies on potency tests for rabies vaccines.
    Wiktor TJ; Atanasiu P; Bahmanyar M; Boegel K; Cox JH; Diaz AM; Fitzgerald EA; Kuwert E; Netter R; Selimov M; Turner G; van Steenis G
    Dev Biol Stand; 1978; 40():171-8. PubMed ID: 355011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the antibody assay in immunized mice for the determination of rabies vaccine potency.
    Fitzgerald EA; Gallagher M; Hunter WS; Seligmann EB
    Dev Biol Stand; 1978; 40():183-6. PubMed ID: 355013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Potency testing of inactivated rabies vaccines with the antibody binding test in comparison with the NIH and habel test(author's transl)].
    Oei HL; Krauss H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):1-14. PubMed ID: 1154901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency testing of diploid-cell rabies vaccine and correlation with immunogenicity.
    Tint H; Rosanoff EI
    Dev Biol Stand; 1978; 40():195-201. PubMed ID: 680393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Questions concerning the potency of rabies vaccine.
    Crick J; Brown F
    Dev Biol Stand; 1978; 40():179-82. PubMed ID: 355012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on candidate reference preparations of rabies vaccine.
    Wiktor TJ; Boegel K; Cox JH; Diaz AM; Fitzgerald E; Netter R; Turner G; Schneider LG; van Steenis G
    Dev Biol Stand; 1978; 40():187-93. PubMed ID: 355014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human rabies globulin and human diploid vaccine dose determinations.
    Hafkin B; Alls ME; Baer GM
    Dev Biol Stand; 1978; 40():121-7. PubMed ID: 680385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody levels following WI38 rabies vaccine.
    Cabasso VJ; Louie RE; Lo B; Dobkin MB
    Dev Biol Stand; 1978; 40():231-5. PubMed ID: 355016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K; Madhusudana SN; Ravi V
    Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine.
    Fitzgerald EA; Needy CF
    Dev Biol Stand; 1986; 64():73-9. PubMed ID: 3098606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Counterimmunoelectrophoresis technique for determining the antigenic potency of rabies vaccine].
    Miceli G; Torroba JE; Diaz AM
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):543-50. PubMed ID: 7997759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of methods used for testing the safety of tissue culture rabies vaccines.
    Romanova LN; Polyushkina GS
    Dev Biol Stand; 1978; 40():209-13. PubMed ID: 680394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potency test which simulates natural exposure for measuring post-exposure activity of rabies vaccines. A proposal for preparing a relevant international reference preparation.
    Bijlenga G
    Dev Biol Stand; 1978; 40():203-8. PubMed ID: 567153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines.
    Krämer B; Schildger H; Behrensdorf-Nicol HA; Hanschmann KM; Duchow K
    Biologicals; 2009 Apr; 37(2):119-26. PubMed ID: 19181541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preventive rabies vaccination using vaccine prepared from human diploid cells].
    Costy-Berger F
    Dev Biol Stand; 1978; 40():101-4. PubMed ID: 680381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of two serological methods for detecting the immune response after rabies vaccination in dogs and cats being exported to rabies-free areas.
    Briggs DJ; Smith JS; Mueller FL; Schwenke J; Davis RD; Gordon CR; Schweitzer K; Orciari LA; Yager PA; Rupprecht CE
    Biologicals; 1998 Dec; 26(4):347-55. PubMed ID: 10403038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
    Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
    Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of two potency tests for antirabies serum: neutralization test in mice (MNT) and rapid fluorescent focus inhibition test (RFFIT).
    Kurz J; Vogel I; Gerstl F; Dostal V
    Dev Biol Stand; 1986; 64():99-107. PubMed ID: 3539671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies with human diploid cell strain rabies vaccine and human antirabies immunoglobulin in man.
    Nicholson KG; Turner GS
    Dev Biol Stand; 1978; 40():115-20. PubMed ID: 680384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.